Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Venanzio Setola, Sergio"'
Autor:
Granata Vincenza, Fusco Roberta, Izzo Francesco, Venanzio Setola Sergio, Coppola Michele, Grassi Roberta, Reginelli Alfonso, Cappabianca Salvatore, Grassi Roberto, Petrillo Antonella
Publikováno v:
Radiology and Oncology, Vol 55, Iss 2, Pp 121-129 (2021)
COVID-19 infection is particularly aggressive in frail patients, as cancer patients. Therefore, the more suitable management of the oncological patient requires a multidisciplinary assessment, to identify which patients should be treated, as inpatien
Externí odkaz:
https://doaj.org/article/769741463ff446e698f1b380a74bdb54
Autor:
Granata Vincenza, Fusco Roberta, Venanzio Setola Sergio, Sandomenico Fabio, Luisa Barretta Maria, Belli Andrea, Palaia Raffaele, Tatangelo Fabiana, Grassi Roberta, Izzo Francesco, Petrillo Antonella
Publikováno v:
Radiology and Oncology, Vol 54, Iss 2, Pp 149-158 (2020)
The aim of the study was to investigate the performance of the Liver Imaging Reporting and Data System (LI-RADS) v2018 for combined hepatocellular-cholangiocarcinoma (cHCC-CCA) identifying the features that allow an accurate characterization.
Externí odkaz:
https://doaj.org/article/ea32ea1f5b0548169c853b34c2f55ffc
Autor:
Costantini, Susan, Di Gennaro, Elena, Capone, Francesca, De Stefano, Alfonso, Nasti, Guglielmo, Vitagliano, Carlo, Venanzio Setola, Sergio, Tatangelo, Fabiana, Delrio, Paolo, Izzo, Francesco, Avallone, Antonio, Budillon, Alfredo
Publikováno v:
Frontiers in Oncology; 1/11/2023, Vol. 13, p1-17, 17p
Autor:
Fusco, Roberta, Sansone, Mario, Granata, Vincenza, Venanzio Setola, Sergio, Petrillo, Antonella
Publikováno v:
Infectious Agents & Cancer; 10/30/2017, Vol. 12, p1-14, 14p, 2 Diagrams, 5 Charts, 5 Graphs
Autor:
Immacolata Paciolla, Laura Arenare, Sabrina Chiara Cecere, Michele Orditura, Daniela Russo, Anna Spina, Carmela Pisano, Laura Attademo, Marilena Di Napoli, Ferdinando De Vita, Jole Ventriglia, Nunzia Simona Losito, Daniela Califano, Sergio Venanzio Setola, Elisena Franzese, Sandro Pignata, Rosa Tambaro
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 31(1)
BackgroundChemotherapy with carboplatin, paclitaxel, and bevacizumab is the standard therapy for patients with advanced stage ovarian cancer wild-type BRCA after primary surgery. The most frequent side effects of bevacizumab in this setting are hyper